MedTrace Logo

Symptomatic Trigeminal Neuralgia Attributed to Multiple Sclerosis - a Prospective Study in 60 Patients

NCT04371575 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-05-01

No results posted yet for this study

Summary

Clinical characteristics, neuroanatomical findings and efficacy of medical and surgical treatment of symptomatic trigeminal neuralgia - a systematic prospective study of 60 consecutive patients

Conditions

Interventions

DRUG

Carbamazepine

There is no actual intervention as the study is observational. First choice tratment is Carbamzepine and Oxcarbazepine. In medically refractory patients, first choice surgery is microvascular decompression

Sponsors & Collaborators

  • Stine Maarbjerg, MD PhD

    lead OTHER

Principal Investigators

  • Lars Bendtsen, Dr Med Sci · Danish Headache Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-01
Primary Completion
2019-12-31
Completion
2019-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04371575 on ClinicalTrials.gov